Names | |
---|---|
IUPAC name 5α-Cholesta-8,24-dien-3β-ol | |
Systematic IUPAC name (1R,3aR,5aS,7S,9aS,11aR)-9a,11a-Dimethyl-1--2,3,3a,4,5,5a,6,7,8,9,9a,10,11,11a-tetradecahydro-1H-cyclopentaphenanthren-7-ol | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChemSpider | |
ECHA InfoCard | 100.004.438 |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C27H4O |
Molar mass | 344.328 g·mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references |
Zymosterol is an intermediate in cholesterol biosynthesis. Disregarding some intermediate compounds (e.g. 4-4-dimethylzymosterol), lanosterol can be considered a precursor of zymosterol in the cholesterol synthesis pathway. The conversion of zymosterol into cholesterol happens in the endoplasmic reticulum. Zymosterol accumulates quickly in the plasma membrane coming from the cytosol. The movement of zymosterol across the cytosol is more than twice as fast as the movement of cholesterol itself.
References
- Dolle, Roland E.; Schmidt, Stanley J.; Erhard, Karl F.; Kruse, Lawrence I. (1989). "Synthesis of zymosterol, fecosterol, and related biosynthetic sterol intermediates". Journal of the American Chemical Society. 111 (1): 278–284. Bibcode:1989JAChS.111..278D. doi:10.1021/ja00183a042.
Cholesterol and steroid metabolic intermediates | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mevalonate pathway |
| ||||||||||
Non-mevalonate pathway | |||||||||||
To Cholesterol | |||||||||||
From Cholesterol to Steroid hormones |
| ||||||||||
Nonhuman |
|
This article about a steroid is a stub. You can help Misplaced Pages by expanding it. |